Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1975;51:614-620

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Norris, R. M.
Right arrow Articles by Small, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Norris, R. M.
Right arrow Articles by Small, C. W.

Circulation, Vol 51, 614-620, Copyright © 1975 by American Heart Association


ARTICLES

Clinical measurement of myocardial infarct size. Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction

RM Norris, RM Whitlock, C Barratt-Boyes and CW Small

A modified method for the measurement of total creatine phosphokinase release from venous blood samples taken four-hourly after myocardial infarction has been used in 43 patients admitted to a Coronary Care Unit. The fractional decay rate (Kd) of enzyme activity has been measured by a standardized method in each patient, and accuracy of the calculation of total enzyme release has been improved by allowance for individual variations in decay rate, and discarding of data from which decay rates cannot be measured within confidence limits of less than plus or minus 15 per cent. Total enzyme release was greater in cases of transmural infarction than in patients with subendocardial infarction, and showed a good positive correlation with clinical indices of the extent of myocardial damage. As noted by previous workers, this method allows for the measurement of the rate as well as the extent of enzyme release, and so should prove useful in the clinical evaluation of therapeutic agents which might accelerate or retard the rate of myocardial necrosis in patients with acute myocardial infarction.


This article has been cited by other articles:


Home page
JAMAHome page
A. Schomig, G. Ndrepepa, and A. Kastrati
Mechanical Reperfusion More Than 12 Hours After Acute Myocardial Infarction--Reply
JAMA, October 26, 2005; 294(16): 2031 - 2032.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Savonitto, C. B. Granger, D. Ardissino, L. Gardner, C. Cavallini, M. Galvani, F. Ottani, H. D. White, P. W. Armstrong, E. M. Ohman, et al.
The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes
J. Am. Coll. Cardiol., January 2, 2002; 39(1): 22 - 29.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. H. Alexander, R. A. Sparapani, K. W. Mahaffey, J. W. Deckers, L. K. Newby, E. M. Ohman, R. Corbalan, S. L. Chierchia, J. B. Boland, M. L. Simoons, et al.
Association Between Minor Elevations of Creatine Kinase-MB Level and Mortality in Patients With Acute Coronary Syndromes Without ST-Segment Elevation
JAMA, January 19, 2000; 283(3): 347 - 353.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. Murakami, S. Kusachi, M. Murakami, I. Sano, T. Uesugi, M. Murakami, R. Hirami, A. Kajiyama, J. Kondo, and T. Tsuji
Time-dependent changes of serum carboxy-terminal peptide of type I procollagen and carboxy-terminal telopeptide of type I collagen concentrations in patients with acute myocardial infarction after successful reperfusion: correlation with left ventricular volume indices
Clin. Chem., December 1, 1998; 44(12): 2453 - 2461.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
L. Coudrey
The Troponins
Arch Intern Med, June 8, 1998; 158(11): 1173 - 1180.
[Full Text] [PDF]


Home page
Med Decis MakingHome page
L. V. Philosophov
Bayesian Decision Making Based on Measurements Containing Errors
Med Decis Making, August 1, 1995; 15(3): 264 - 275.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
J. Y. Wei, J. E. Markis, M. Malagold, and W. Grossman
Time Course of Serum Cardiac Enzymes After Intracoronary Thrombolytic Therapy: Creatine Kinase, Creatine Kinase MB Isozyme, Lactate Dehydrogenase, and Serum Glutamic-Oxaloacetic Transaminase
Arch Intern Med, September 1, 1985; 145(9): 1596 - 1600.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
R. E. RUDE, J. E. MULLER, and B. EUGENE
Efforts to Limit the Size of Myocardial Infarcts
Ann Intern Med, December 1, 1981; 95(6): 736 - 761.
[Abstract] [PDF]